Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 19:15:100423.
doi: 10.1016/j.conctc.2019.100423. eCollection 2019 Sep.

Resources to assist in the transition to a single IRB model for multisite clinical trials

Affiliations

Resources to assist in the transition to a single IRB model for multisite clinical trials

Cynthia Hahn et al. Contemp Clin Trials Commun. .
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Timeline of single IRB requirements and release of implementation Resources Abbreviations: ANPRM = Advance notice of proposed rulemaking; CTTI=Clinical trials transformation initiative; FDA=Food and drug administration; IAA=IRB Authorization agreement; IRB=Instituional review board; NCATS=National center for advancing Translational sciences; NEJM=New england journal of medicine; NIH=National institutes of health; NPRM=Notice of proposed rulemaking; SMART=Streamlined, Multisite, Accelerated resources for trials.

References

    1. National Institutes of Health Final NIH policy on the use of a single institutional review board for multi-site research. https://grants.nih.gov/grants/guide/notice-files/NOT-OD-16-094.html
    1. Department of Homeland Security Federal policy for the protection of human subjects. Fed. Regist. 2017;82(12):7149–7274. https://www.federalregister.gov/documents/2017/01/19/2017-01058/federal-... Available at. - PubMed
    1. Abbott D., Califf R., Morrison B.W., Pierre C., Bolte J., Chakraborty S. Cycle time metrics for multisite clinical trials in the United States. Ther Innov Regul Sci. 2013;47:152–160. - PubMed
    1. Ravina B., Deuel L., Siderowf A., Dorsey E.R. Local institutional review board (IRB) review of a multicenter trial: local costs without local context. Ann. Neurol. 2010;67:258–260. - PMC - PubMed
    1. Wagner T.H., Murray C., Goldberg J., Adler J.M., Abrams J. Costs and benefits of the National Cancer Institute central institutional review board. J. Clin. Oncol. 2010;28:662–666. - PMC - PubMed

LinkOut - more resources